tsh biopharmoration Ltd (8432) — Financial Flexibility Index
tsh biopharmoration Ltd (8432) has a Financial Flexibility Index of 0.17x as of June 2025. Free cash flow of NT$45.82 Million (operating CF NT$42.55 Million minus capex NT$3.27 Million) represents 0% of total liabilities (NT$273.54 Million). Check 8432 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
tsh biopharmoration Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for tsh biopharmoration Ltd across 8 annual periods. See tsh biopharmoration Ltd (8432) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for tsh biopharmoration Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for tsh biopharmoration Ltd. For the full company profile including market capitalisation, see tsh biopharmoration Ltd (8432) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.85x | NT$186.51 Million | NT$183.77 Million | NT$219.22 Million | ▲ +188.3% |
| 2023 | 0.30x | NT$39.43 Million | NT$33.87 Million | NT$133.63 Million | ▲ +23.7% |
| 2022 | 0.24x | NT$53.08 Million | NT$34.35 Million | NT$222.46 Million | ▼ -70.4% |
| 2021 | 0.81x | NT$69.09 Million | NT$68.71 Million | NT$85.80 Million | ▲ +493.1% |
| 2020 | 0.14x | NT$13.99 Million | NT$11.61 Million | NT$103.04 Million | ▼ -79.4% |
| 2019 | 0.66x | NT$91.64 Million | NT$88.65 Million | NT$138.79 Million | ▼ -4.1% |
| 2018 | 0.69x | NT$68.50 Million | NT$62.62 Million | NT$99.44 Million | ▲ +8.6% |
| 2017 | 0.63x | NT$85.70 Million | NT$81.13 Million | NT$135.08 Million | — |